It has been reported that ZBTB7A also acts as a key transcription factor in tumor cells, is closely related to the transcriptional regulation of key glycolytic enzymes, and transcriptionally represses GLUT‐3, PFKP, and PKM2 expression, affecting tumor progression and patient prognosis.43, 44. The gene discussed is ZBTB7A; the disease is neoplasm.